KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Common Equity (2016 - 2025)

Historic Common Equity for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to $10.1 billion.

  • Lam Research's Common Equity rose 1518.39% to $10.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.1 billion, marking a year-over-year increase of 1518.39%. This contributed to the annual value of $9.9 billion for FY2025, which is 1548.3% up from last year.
  • As of Q4 2025, Lam Research's Common Equity stood at $10.1 billion, which was up 1518.39% from $10.2 billion recorded in Q3 2025.
  • In the past 5 years, Lam Research's Common Equity ranged from a high of $10.2 billion in Q3 2025 and a low of $5.4 billion during Q1 2021
  • Moreover, its 5-year median value for Common Equity was $8.2 billion (2023), whereas its average is $7.9 billion.
  • In the last 5 years, Lam Research's Common Equity skyrocketed by 3950.72% in 2023 and then tumbled by 458.27% in 2024.
  • Over the past 5 years, Lam Research's Common Equity (Quarter) stood at $6.5 billion in 2021, then grew by 28.24% to $8.3 billion in 2022, then decreased by 0.99% to $8.2 billion in 2023, then grew by 7.12% to $8.8 billion in 2024, then increased by 15.18% to $10.1 billion in 2025.
  • Its Common Equity stands at $10.1 billion for Q4 2025, versus $10.2 billion for Q3 2025 and $9.9 billion for Q2 2025.